CS
COEPW

Clear Street’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Clear Street’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,894
Closed -$57 – 1407
2026
Q1 		$57 Hold
4,894
– – ﹤0.01% 1079
2025
Q4 		$53 Sell
4,894
-100
-2% -$2 ﹤0.01% 907
2025
Q3 		$131 Buy
4,994
+4,794
+2,397% +$127 ﹤0.01% 805
2025
Q2 		$6 Buy
+200
New +$4 ﹤0.01% 671
2025
Q1 		– Sell
-26,912
Closed -$592 – 584
2024
Q4 		$592 Buy
26,912
+24,700
+1,117% +$590 ﹤0.01% 510
2024
Q3 		$33 Buy
2,212
+121
+6% +$2 ﹤0.01% 678
2024
Q2 		$63 Hold
2,091
– – ﹤0.01% 747
2024
Q1 		$53 Buy
2,091
+100
+5% +$4 ﹤0.01% 746
2023
Q4 		$62 Buy
1,991
+391
+24% +$15 ﹤0.01% 772
2023
Q3 		$36 Buy
1,600
+200
+14% +$8 ﹤0.01% 1052
2023
Q2 		$100 Hold
1,400
– – ﹤0.01% 1213
2023
Q1 		$206 Hold
1,400
– – ﹤0.01% 1072
2022
Q4 		$0 Hold
1,400
– – ﹤0.01% 1081
2022
Q3 		$0 Hold
1,400
– – ﹤0.01% 1185
2022
Q2 		$0 Buy
+1,400
New +$105 ﹤0.01% 1032

Other funds holding COEPW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Clear Street's COEPW Position: Q2 2026 in Review

Clear Street sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2026, closing a stake of 4,894 shares — an estimated $57 sold.

Clear Street first reported a position in COEPW in Q2 2022 and held it in 15 quarters. The position peaked at $592 in Q4 2024. 3 funds tracked by Wall St. Rank hold COEPW as of Q2 2026.

  • Clear Street reported no remaining Coeptis Therapeutics Warrants position as of Q2 2026 after selling out during the quarter.
  • Clear Street sold 4,894 Coeptis Therapeutics Warrants shares in Q2 2026, an estimated $57.
  • Clear Street first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 15 quarters.
  • Clear Street's Coeptis Therapeutics Warrants position peaked at $592 in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.